OR52E8 Inhibitors
OR52E8 inhibitors represent a class of chemical compounds that specifically target and modulate the activity of the OR52E8 protein, a member of the olfactory receptor (OR) family. Olfactory receptors, which are part of the G-protein coupled receptor (GPCR) superfamily, are typically associated with the detection of volatile odorants in the olfactory system. However, OR52E8, like many other olfactory receptors, has been found to exhibit expression in non-olfactory tissues, suggesting a broader biological role. Inhibitors of OR52E8 are designed to reduce or block the receptor's activity, thereby influencing the signaling pathways that the receptor is involved in. These pathways often rely on the interaction between the receptor and its ligands, triggering conformational changes that activate downstream molecular events. The inhibition of this receptor can prevent these molecular signals from being transmitted, potentially leading to a variety of downstream biochemical consequences.
The specificity of OR52E8 inhibitors lies in their ability to selectively bind to the OR52E8 receptor without affecting other olfactory receptors or GPCRs. This selective interaction typically results from the unique binding sites present on OR52E8, which differ from those of other receptors. By modulating this receptor's activity, OR52E8 inhibitors provide researchers with tools to explore the specific biological functions of this receptor, including its signaling mechanisms and regulatory roles in various cellular processes. The study of these inhibitors sheds light on the structural and functional properties of OR52E8 and its broader involvement in non-olfactory signaling networks, contributing to a deeper understanding of receptor-based signaling cascades. These compounds play a crucial role in elucidating the complex interactions within the GPCR superfamily, expanding the knowledge of how olfactory receptors may function beyond their traditional roles in the sensory system.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
This histone deacetylase inhibitor could condense the chromatin structure around the OR52E8 gene promoter, which would likely lead to a downregulation of its transcription by making the gene less accessible to transcriptional machinery. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferase, 5-Azacytidine could cause hypomethylation of the OR52E8 gene locus, which may lead to a subsequent reduction in gene expression due to changes in the chromatin architecture that silence gene activity. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG 108 may prevent methylation of the promoter region of the OR52E8 gene, resulting in the suppression of gene transcription through the alteration of epigenetic markers that are typically associated with active gene expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid (Vorinostat) could remove acetyl groups from histones associated with the OR52E8 gene, leading to tighter chromatin packing and a decrease in OR52E8 expression by restricting access of transcription factors and RNA polymerase. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
5-Aza-2′-Deoxycytidine (Decitabine) could lead to the demethylation of DNA within the regulatory regions of the OR52E8 gene, which could silence the gene expression by creating a chromatin environment that is not permissive to transcription. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
By selectively inhibiting histone deacetylases, MS-275 (Entinostat) could induce hypoacetylation of histones at the OR52E8 locus, potentially resulting in a repressive chromatin state and a consequent decrease in gene expression. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
As a potent histone deacetylase inhibitor, Romidepsin could lead to the remodeling of chromatin structure at the OR52E8 gene site, thereby silencing gene expression through the establishment of a transcriptionally inactive chromatin state. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A can bind to specific DNA sequences and could conceivably interfere with the binding of transcription factors to the promoter region of OR52E8, reducing the gene′s expression by blocking the initiation of transcription. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine, primarily known for its antimalarial action, could disrupt lysosomal function and indirectly lead to the downregulation of OR52E8 expression by affecting the cellular environment and signaling pathways related to gene expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
By intercalating into DNA, Actinomycin D could block the transcriptional elongation process of the OR52E8 gene, leading to a direct inhibition of its mRNA synthesis and subsequent protein expression. | ||||||